TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31801982

Group type: COMPARATOR
Intervention: Condition with a standardized breakfast used to calculate SQ (C1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Condition with the same breakfast and ad libitum lunch and dinner buffet meals (C2)
Number of subjects: 68
Study: 29661563

Group type: EXPERIMENTAL
Intervention: Home Medication Management Review (HMMR) service
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no HMMR service)
Number of subjects: 106
Study: 28875866

Group type: EXPERIMENTAL
Intervention: Ferrous fumarate (FeFum)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sodium iron EDTA (NaFeEDTA)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of FeFum and NaFeEDTA (FeFum+NaFeEDTA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Helicobacter pylori infection
Number of subjects: 22
Study: 25840875

Group type: COMPARATOR
Intervention: Standard sedation (fentanyl 1 μg/kg + midazolam 0.03-0.04 mg/kg or midazolam only)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Propofol Target Controlled Infusion (1.2-1.6 μg/ml)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Propofol group
Number of subjects: 140
Study: 23878443

Group type: EXPERIMENTAL
Intervention: Betahistine 16 mg plus ondansetron 8 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo plus ondansetron 8 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Betahistine group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 100
Study: 21266216

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) technology for detecting surgical sponges
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (subjects served as their own controls)
Number of subjects: 210
Study: 19514185

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Drug group (Nimodipine)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EA plus drug group (EA + Nimodipine)
Number of subjects: 90
Study: 16778124

Group type: EXPERIMENTAL
Intervention: ALOX5AP gene variants (HapA, HapB)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control group (age- and smoking-matched participants)
Number of subjects: 1200
Study: 15364709

Group type: EXPERIMENTAL
Intervention: docosahexaenoic acid (1200 mg/d) plus 15,000 IU/d of vitamin A (DHA + A group)
Number of subjects: 208

Group type: COMPARATOR
Intervention: control fatty acid plus 15,000 IU/d of vitamin A (control + A group)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: diet rich in omega-3 fatty acids (>=0.20 g/d)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: duration of vitamin A supplementation prior to entry
Number of subjects: 208
Study: 11206599

Group type: EXPERIMENTAL
Intervention: Intramuscular ziprasidone
Number of subjects: 132

Group type: COMPARATOR
Intervention: Intramuscular haloperidol
Number of subjects: 132
Study: 9377284

Group type: EXPERIMENTAL
Intervention: Optic nerve decompression surgery
Number of subjects: 305

Group type: COMPARATOR
Intervention: Careful follow-up
Number of subjects: 305
Study: 8222487

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study: 2869304

Group type: EXPERIMENTAL
Intervention: Knowledge of left-ventricular ejection fraction (LVEF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no knowledge of LVEF)
Number of subjects: 60
Study: 31933345

Group type: EXPERIMENTAL
Intervention: Indoor Cycling (IC)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Indoor Cycling + Zumba (IC+ZU)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Indoor Cycling + Body Pump (IC+BP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 48
Study: 29866304

Group type: EXPERIMENTAL
Intervention: Coffee (100 mg caffeine)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 69
Study: 27322586

Group type: EXPERIMENTAL
Intervention: 18F-FMISO PET/CT
Number of subjects: 42

Group type: COMPARATOR
Intervention: 18F-FETNIM PET/CT
Number of subjects: 42
Study: 25171029

Group type: EXPERIMENTAL
Intervention: Autologous blood injection (group A, n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Diluted epinephrine injection (group B, n=50)
Number of subjects: 100
Study: 22822992

Group type: EXPERIMENTAL
Intervention: MDZ (0.02 mg/kg) followed by 0.01 mg/kg every 45 minutes + DEX (2 µg/kg/h for 10 minutes, then 0.5 µg/kg/h)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MDZ (0.02 mg/kg) followed by 0.01 mg/kg every 45 minutes + DEX (1 µg/kg/h for 10 minutes, then 0.3 µg/kg/h)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: MDZ (0.03 mg/kg) followed by 0.01 mg/kg every 30 minutes + DEX (1 µg/kg/h for 10 minutes, then 0.3 µg/kg/h)
Number of subjects: 43

Group type: COMPARATOR
Intervention: DEX (2 µg/kg/h for 10 minutes, then 0.5 µg/kg/h) without MDZ
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 43
Study: 20711563

Group type: EXPERIMENTAL
Intervention: Antisaccade task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saccade task
Number of subjects: 12
Study: 18978162

Group type: EXPERIMENTAL
Intervention: Probiotic capsules containing Lactobacillus rhamnosus LC705 and Propionibacterium freudenreichii ssp shermanii JS (2 x 10^10 colony forming units of each strain daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 38
Study: 15795723

Group type: EXPERIMENTAL
Intervention: Laptop-based interactive computer program
Number of subjects: 655

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 655
Study: 12623916

Group type: EXPERIMENTAL
Intervention: Structured abstract with low importance of results
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Structured abstract with high importance of results
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Structured abstract with low validity of methods
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Structured abstract with high validity of methods
Number of subjects: 164
Study: 10692752

Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 6 mg
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 12.5 mg
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: sumatriptan suppository 25 mg
Number of subjects: 431
Study: 8739614

Group type: EXPERIMENTAL
Intervention: 24 training trials with intermodality change stimulus
Number of subjects: 128

Group type: COMPARATOR
Intervention: 24 training trials with no-change stimulus
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 6 training trials with intermodality change stimulus
Number of subjects: 128

Group type: COMPARATOR
Intervention: 6 training trials with no-change stimulus
Number of subjects: 128
Study: 1864450

Group type: EXPERIMENTAL
Intervention: Oleum horwathiensis
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 6310833

Group type: EXPERIMENTAL
Intervention: Cyclosporine alone for 3 months followed by conversion to azathioprine and prednisolone (AP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional treatment with azathioprine and prednisolone (AP)
Number of subjects: 35
Study: 31752638

Group type: EXPERIMENTAL
Intervention: febuxostat alone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: febuxostat together with rasburicase
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 25040234

Group type: EXPERIMENTAL
Intervention: Oral cancer screening via mass media campaign and dental visits to a public hospital
Number of subjects: 727
Study: 24435105

Group type: EXPERIMENTAL
Intervention: Equipment-based Pilates
Number of subjects: 86

Group type: COMPARATOR
Intervention: Mat Pilates
Number of subjects: 86
Study: 22845614

Group type: EXPERIMENTAL
Intervention: Apically positioned flap
Number of subjects: 30

Group type: COMPARATOR
Intervention: Modified Widman flap
Number of subjects: 30
Study: 18553116

Group type: EXPERIMENTAL
Intervention: CO2 laser protocol 1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CO2 laser protocol 2
Number of subjects: 40
Study: 17332962

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Both groups (LC and OC)
Number of subjects: 114
Study: 15383108

Group type: EXPERIMENTAL
Intervention: Planned caesarean
Number of subjects: 0

Group type: COMPARATOR
Intervention: Planned vaginal birth
Number of subjects: 0
Study: 11274583

Group type: EXPERIMENTAL
Intervention: Plasma from multiparous donors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control plasma
Number of subjects: 100
Study: 9603093

Group type: EXPERIMENTAL
Intervention: Percutaneous DPL using an 18-gauge Veress needle
Number of subjects: 176

Group type: COMPARATOR
Intervention: Open DPL using a standard technique
Number of subjects: 176
Study: 7826960

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted bilateral salpingo-oophorectomy and vaginal hysterectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy and bilateral salpingo-oophorectomy
Number of subjects: 80
Study: 3293828

Group type: EXPERIMENTAL
Intervention: Halofantrine (1000 mg followed by 500 mg 6 hours later)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Halofantrine (500 mg every 6 hours for 3 doses)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Mefloquine (1000 mg single dose)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Mefloquine (1500 mg single dose)
Number of subjects: 82
Study: 31951819

Group type: EXPERIMENTAL
Intervention: 250 mg D-cycloserine (DCS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30461578

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 11
Study: 29033015

Group type: EXPERIMENTAL
Intervention: Routine pleural drainage using a 28F chest tube for 2 consecutive days (group I)
Number of subjects: 103

Group type: COMPARATOR
Intervention: No pleural drainage (group II)
Number of subjects: 103
Study: 26155952

Group type: EXPERIMENTAL
Intervention: Active ultrasound treatment by CellsonicTM on one arm (30 minutes, 5 treatments)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control arm (no treatment)
Number of subjects: 14
Study: 23188626

Group type: EXPERIMENTAL
Intervention: Exercise with regadenoson-as-necessary (Ex-Reg, n=96)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Dipyridamole with exercise (Dip-Ex, n=44)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Exercise with regadenoson-as-necessary (Ex-Reg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Dipyridamole with exercise (Dip-Ex)
Number of subjects: 140
Study: 21517801

Group type: EXPERIMENTAL
Intervention: Low-dose 5-fluorouracil 0.5%/salicylic acid 10.0% (Actikerall®)
Number of subjects: 470

Group type: COMPARATOR
Intervention: Diclofenac 3% in hyaluronic acid (diclofenac HA)
Number of subjects: 470

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 470
Study: 17949894

Group type: EXPERIMENTAL
Intervention: F wave studies
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: F wave parameters
Number of subjects: 31
Study: 16531594

Group type: EXPERIMENTAL
Intervention: Intervention by firefighters (community-based intervention including a heart attack survival kit with aspirin)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20000
Study: 14522812

Group type: EXPERIMENTAL
Intervention: Standardized care in emergency departments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggressive treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intense treatment for airway obstruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current therapeutic options (ipratropium and corticosteroids with beta2 selective drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Near-fatal episodes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical intensive care unit admissions
Number of subjects: 0
Study: 10580176

Group type: EXPERIMENTAL
Intervention: Vegetable oil based stanols (3.8 g; 2.6 g sitostanol plus 1.2 g campestanol)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Pine wood based stanols (4 g; 3.7 g sitostanol plus 0.3 g campestanol)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study: 8849849

Group type: EXPERIMENTAL
Intervention: 20 mg ketorolac tromethamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1387930

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg i.v.)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Alizapride plus methylprednisolone (ALI/MPS)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 220
Study: 6149126

Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Oxprenolol (2 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3511199

Group type: EXPERIMENTAL
Intervention: SnF2‐polycarboxylate cement (72 mg F‐); placed in molars for 34 days (safety trial)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: SnF2‐polycarboxylate restoration; placed in molars during a 2 week period of no oral hygiene (efficacy trial)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo restoration; placed in molars during a 2 week period of no oral hygiene (efficacy trial)
Number of subjects: 22
Study: 30702226

Group type: EXPERIMENTAL
Intervention: Different water drinking behavior
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 26721536

Group type: EXPERIMENTAL
Intervention: Technician barcode scanning
Number of subjects: 2015

Group type: COMPARATOR
Intervention: Pharmacist visual checks
Number of subjects: 2015
Study: 24998012

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg with telmisartan 80 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg with rosuvastatin 20 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combination therapy (rosuvastatin and telmisartan)
Number of subjects: 60
Study: 24231013

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Traditional total parenteral nutrition
Number of subjects: 77
Study: 19669690

Group type: EXPERIMENTAL
Intervention: Radical excision of the lesion
Number of subjects: 2
Study: 18923572

Group type: EXPERIMENTAL
Intervention: Ginseng (1125 mg.d‐1)
Number of subjects: 10
Study: 16374152

Group type: EXPERIMENTAL
Intervention: Corticosteroids (50 mg hydrocortisone every 6 hrs and 50 microg of 9-alpha-fludrocortisone once a day for 7 days)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 300
Study: 14609804

Group type: EXPERIMENTAL
Intervention: Risperidone (1 mg to 3 mg/day)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg to 20 mg/day)
Number of subjects: 175
Study: 10338105

Group type: EXPERIMENTAL
Intervention: 12g piracetam daily for 4 weeks and maintenance treatment for a further 8 weeks
Number of subjects: 927

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 927
Study: 8704693

Group type: EXPERIMENTAL
Intervention: Prednisone and cyclosporin A (CsA)
Number of subjects: 9
Study: 1792797

Group type: EXPERIMENTAL
Intervention: Danazol 400 mg daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional treatment with prolactin antagonist and progesterone
Number of subjects: 26
Study: 6342126

Group type: EXPERIMENTAL
Intervention: Group 1 (12 patients) - antibiotics stopped for 18 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Group 2 (11 patients) - received antibiotics when necessary for 18 months
Number of subjects: 23
Study: 31028826

Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 79
Study: 30085149

Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with chloroquine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with dihydroartemisinin/piperaquine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Primaquine co-administered with pyronaridine/artesunate
Number of subjects: 49

Group type: COMPARATOR
Intervention: Primaquine alone
Number of subjects: 49
Study: 27212774

Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 70

Group type: COMPARATOR
Intervention: 2% lignocaine
Number of subjects: 70
Study: 24972254

Group type: EXPERIMENTAL
Intervention: High-frequency oscillation (HFO)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 319
Study: 22542120

Group type: EXPERIMENTAL
Intervention: newly developed preeclampsia educational tool
Number of subjects: 120

Group type: COMPARATOR
Intervention: standard pamphlet by the American College of Obstetricians and Gynecologists
Number of subjects: 120

Group type: COMPARATOR
Intervention: no additional information
Number of subjects: 120
Study: 20507811

Group type: EXPERIMENTAL
Intervention: Rubber dam isolation method
Number of subjects: 804

Group type: COMPARATOR
Intervention: Cotton wool rolls isolation method
Number of subjects: 804
Study: 18608843

Group type: EXPERIMENTAL
Intervention: Intervention schools (health education and physical activity)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 17
Study: 16099352

Group type: EXPERIMENTAL
Intervention: Consistent truthful condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consistent deceptive condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random deceptive condition
Number of subjects: 0
Study: 11587995

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9877351

Group type: EXPERIMENTAL
Intervention: More information and more time to reflect
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Optimal level of information about side-effects
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: More information in general
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Less information
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: High levels of knowledge before participation
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Optimal amount of information
Number of subjects: 812
Study: 7979491

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (Genotropin) 30 IU/m2/week
Number of subjects: 41

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 41
Study: 2596656

Group type: EXPERIMENTAL
Intervention: Fibrescope-guided nasotracheal intubation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Macintosh laryngoscope intubation
Number of subjects: 60
Study: 1026550

Group type: EXPERIMENTAL
Intervention: Micro-encapsulated aspirin (Levius)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Aloxiprin (Palaprin Forte)
Number of subjects: 33
Study: 30837419

Group type: COMPARATOR
Intervention: Direct composite (control)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Composite with fiber on occlusal level (KO)
Number of subjects: 210
Study: 29945727

Group type: EXPERIMENTAL
Intervention: MEDI0382
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 27298051

Group type: EXPERIMENTAL
Intervention: Perioperative pain neuroscience education (brain school)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Perioperative back school (control)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups (usual preoperative and postoperative care)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 86
Study: 24059744

Group type: EXPERIMENTAL
Intervention: Systemic doxycycline (DOXY) 200 mg per day for 7 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 57
Study: 21494193

Group type: EXPERIMENTAL
Intervention: Symptom-guided exercises + information + advice to stay active
Number of subjects: 181

Group type: COMPARATOR
Intervention: Sham exercises + information + advice to stay active
Number of subjects: 181
Study: 19244055

Group type: EXPERIMENTAL
Intervention: CT bronchoscopic simulation guidance
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional orientation using axial CT sections
Number of subjects: 28
Study: 17973063

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine course and case-method learning sessions (4 months, bi-weekly)
Number of subjects: 106
Study: 15368623

Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 61

Group type: COMPARATOR
Intervention: Polyglactin 910 (vicryl) sutures
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Stainless steel sutures
Number of subjects: 61
Study: 11141142

Group type: EXPERIMENTAL
Intervention: Cholesterol lowering treatments (dietary modification, drug treatment, or partial ileal bypass surgery for 1-10 years)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Primary prevention trials
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Secondary prevention trials
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dietary interventions and non-statin drugs
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnitude of cholesterol reduction
Number of subjects: 19
Study: 9088856

Group type: EXPERIMENTAL
Intervention: Euglycaemic insulin clamp after heavy, glycogen-depleting exercise
Number of subjects: 26

Group type: COMPARATOR
Intervention: Euglycaemic insulin clamp after resting control day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Correlation of basal serum leptin concentration
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Serum leptin after hyperinsulinaemia
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Basal serum leptin level after exercise
Number of subjects: 26
Study: 7522287

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, once daily)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg, twice daily)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97